Literature DB >> 9514809

Telomerase activity in the female reproductive tract and neoplasms.

Y Yokoyama1, Y Takahashi, A Shinohara, Z Lian, T Tamaya.   

Abstract

OBJECTIVE: To study a possible utility of telomerase determination for cancer diagnosis.
METHODS: In a total of 227 tissue samples comprising 114 normal tissues of the reproductive age, 10 fallopian tubes of the postmenopausal age, and 103 neoplastic tissues from female reproductive tracts, telomerase activity was determined. Using densitometrical analysis, telomerase activity was compared between carcinoma tissues and normal counterparts.
RESULTS: A total of 97.3% (71/73) of cancer samples comprising ovarian carcinoma, endometrial carcinoma, and epidermoid carcinoma of the cervix and 89.5% (77/86) of the epithelia of the reproductive-aged uterus and fallopian tube showed telomerase activity. The epithelia of the fallopian tube of reproductive age showed significantly higher frequency of positivity (16/18) than the postmenopausal epithelia of the tube (3/10). No difference in telomerase activity was found between endometrial carcinomas and normal proliferative endometria. A significantly higher activity was found in ovarian epithelial carcinoma and epidermoid carcinoma of the cervix than in normal counterparts, although 92% (11/12) of the normal exocervix and 30% (3/10) of the normal ovary showed telomerase activity.
CONCLUSIONS: Most epithelia of the female reproductive tract maintain telomerase activity during the reproductive age. Therefore, the detection of malignancies by telomerase determination may be feasible in ovarian carcinoma and epidermoid carcinoma of the cervix, but requires accurate quantification of telomerase activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514809     DOI: 10.1006/gyno.1997.4921

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk.

Authors:  Kathryn L Terry; Shelley S Tworoger; Allison F Vitonis; Jason Wong; Linda Titus-Ernstoff; Immaculata De Vivo; Daniel W Cramer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-01-20       Impact factor: 4.254

2.  Rapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatment.

Authors:  Victoria L Bae-Jump; Chunxiao Zhou; John F Boggess; Young E Whang; Lisa Barroilhet; Paola A Gehrig
Journal:  Gynecol Oncol       Date:  2010-09-21       Impact factor: 5.482

3.  Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway.

Authors:  Rabbie K Hanna; Chunxiao Zhou; Kimberly M Malloy; Li Sun; Yan Zhong; Paola A Gehrig; Victoria L Bae-Jump
Journal:  Gynecol Oncol       Date:  2012-01-16       Impact factor: 5.482

4.  Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy.

Authors:  Leigh A Cantrell; Chunxiao Zhou; Alberto Mendivil; Kimberly M Malloy; Paola A Gehrig; Victoria L Bae-Jump
Journal:  Gynecol Oncol       Date:  2009-10-12       Impact factor: 5.482

5.  Immunohistochemical expression of ubiquitin and telomerase in cervical cancer.

Authors:  Toro de Méndez Morelva; Llombart Bosch Antonio
Journal:  Virchows Arch       Date:  2009-08-14       Impact factor: 4.064

6.  Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis.

Authors:  Aaron Shafer; Chunxiao Zhou; Paola A Gehrig; John F Boggess; Victoria L Bae-Jump
Journal:  Int J Cancer       Date:  2010-03-01       Impact factor: 7.396

Review 7.  Epigenetics of cervical cancer. An overview and therapeutic perspectives.

Authors:  Alfonso Dueñas-González; Marcela Lizano; Myrna Candelaria; Lucely Cetina; Claudia Arce; Eduardo Cervera
Journal:  Mol Cancer       Date:  2005-10-25       Impact factor: 27.401

Review 8.  An introduction to telomeres and telomerase.

Authors:  Michael C Bibby
Journal:  Mol Biotechnol       Date:  2003-07       Impact factor: 2.860

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.